RT Book, Section A1 Beauduy, Camille E. A1 Winston, Lisa G. A2 Katzung, Bertram G. A2 Vanderah, Todd W. SR Print(0) ID 1176468982 T1 Tetracyclines, Macrolides, Clindamycin, Chloramphenicol, Streptogramins, Oxazolidinones, & Pleuromutilins T2 Basic & Clinical Pharmacology, 15e YR 2021 FD 2021 PB McGraw-Hill PP New York, NY SN 9781260452310 LK accesspharmacy.mhmedical.com/content.aspx?aid=1176468982 RD 2024/03/29 AB CASE STUDYA 22-year-old woman presents to her college medical clinic complaining of a 2-week history of vaginal discharge. She has not had fever or abdominal pain. She has had vaginal intercourse with two men in the last 6 months and used condoms intermittently. A pelvic examination is performed and is positive for mucopurulent discharge from the endocervical canal. No cervical motion tenderness is present. A first-catch urine specimen is obtained for chlamydia and gonorrhea nucleic acid amplification testing. A pregnancy test is also ordered, and the patient reports she “missed her last period.” Pending these results, the decision is made to treat her presumptively for chlamydial cervicitis. What are two potential treatment options for her possible chlamydial infection? How does her potential pregnancy affect the treatment decision?